Drugs & medicalClass III

QuVa Pharma, Inc. recalls oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Compounded Product for…

Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).

Read the official notice →
Date
2022-10-05
Country
United States
Brand
QuVa Pharma
Product
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Compounded Product for…
Classification
Class III
Units
Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More QuVa Pharma recalls

  1. 2026-07-15
  2. US
    Drugs & medicalClass II

    QuVa Pharma, Inc. recalls Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100,…

    Failed Impurities/Degradation Specifications

    FDA · DrugQuVa Pharma, Inc.Nationwide within the United StatesOfficial notice →
  3. 2025-11-05
  4. US
  5. 2025-04-02
  6. US
All 4 QuVa Pharma recalls →

Other drugs & medical recalls in the United States

  1. 2022-10-05
  2. US
    Drugs & medicalClass II

    Akorn, Inc. recalls Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031, NDC 61748-015-30

    Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

    FDA · DrugAkorn, Inc.USA Nationwide and Puerto RicoOfficial notice →
  3. US
    Drugs & medicalClass III

    Leading Pharma, LLC recalls ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC,…

    Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules

    FDA · DrugLeading Pharma, LLCNationwide within the United StatesOfficial notice →
  4. US
  5. US
    Drugs & medicalClass II

    Novartis Pharmaceuticals Corporation recalls Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton,…

    CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.

    FDA · DrugNovartis Pharmaceuticals CorporationNationwide and Puerto RicoOfficial notice →
  6. US
    Drugs & medicalClass II

    Viatris Inc recalls Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan…

    Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.

    FDA · DrugViatris IncNationwide in the USAOfficial notice →
  7. US
    Drugs & medicalClass III

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Rx Only, 90 Capsules per bottle, Manufactured by: Ohm Laboratories…

    Superpotent Drug: Out of specification for assay at the 12-month timepoint.

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCNationwide in the USAOfficial notice →
See all drugs & medical recalls →